Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism LCAT agonists(Phosphatidylcholine-sterol acyltransferase agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17F6N5O2 |
InChIKeyHNXQXQMRFKVNKY-MRXNPFEDSA-N |
CAS Registry1799367-76-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Preclinical | Japan | 22 Oct 2020 |





